Erythropoietin Improves Long-Term Outcomes in Patients with Acute Kidney Injury after Coronary Artery Bypass Grafting Full Text
Journal of Korean Medical Science,

Oh SW et al. – Erythropoietin (EPO) reduces all–cause–mortality and end stage renal disease in patients with acute kidney injury (AKI), largely due to the beneficial effect of EPO on recovery after AKI.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Cardiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Cardiology Articles

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore